Información:
Error:
ID
13960
Descripción
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02204059
Link
https://clinicaltrials.gov/show/NCT02204059
Palabras clave
Versiones (1)
- 20/3/16 20/3/16 -
Subido en
20 de marzo de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Carcinoma, Non-Small-Cell Lung NCT02204059
Eligibility Carcinoma, Non-Small-Cell Lung NCT02204059
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT02204059
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Staging
Item
patients must have histological or cytological confirmation of non small cell lung cancer (nsclc) stage i, ii or iiia according to the staging system of the american joint committee on cancer (ajcc)
boolean
C0280217 (UMLS CUI [1])
Tumour resection
Item
patients destined for resection of the tumour
boolean
C0728940 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
Age
Item
patients over 18 years of age
boolean
C0001779 (UMLS CUI [1])
Age
Item
patients younger than 80 years of age
boolean
C0001779 (UMLS CUI [1])
Written informed consent
Item
patients who had given 'written informed consent'
boolean
C0021430 (UMLS CUI [1])
Life expectancy
Item
patients with a life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
Karnofsky Performance Status
Item
patients with a good performance status: karnofsky > 60
boolean
C0206065 (UMLS CUI [1])
Comorbidity
Item
life-threatening infection, allergic diathesis, organ failure (bilirubin > 30µmol/l and/or creatinine > 150 µmol/l) or evidence of a recent myocardial infarction on electrocardiogram (ecg) or unstable angina pectoris
boolean
C0009488 (UMLS CUI [1])
Pre-menopausal status
Item
pre-menopausal women (last menstruation <= 1 year prior to study start)
boolean
C0279752 (UMLS CUI [1])
Hysterectomy, tubal ligation
Item
not surgically sterile (hysterectomy, tubal ligation) and
boolean
C0020699 (UMLS CUI [1])
C0520483 (UMLS CUI [2])
C0520483 (UMLS CUI [2])
Contraceptive methods
Item
not practicing acceptable means of birth control, (or not planned to be continued throughout the study). acceptable methods of birth control include oral, implantable or injectable contraceptives
boolean
C0700589 (UMLS CUI [1])
Pregnancy
Item
women with a positive serum pregnancy test at baseline
boolean
C0032961 (UMLS CUI [1])
Laboratory parameters and prior therapy
Item
white blood cell count < 3000/mm³, granulocyte count < 1500/mm³ or platelet count < 100000/mm³. details of prior chemotherapy and radiotherapy had to be known.
boolean
C0023508 (UMLS CUI [1])
C0857490 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
C0857490 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
Comorbidity
Item
hematological disorders, congestive heart failure, bronchial asthma, alimentary or contact allergy, severe atopy or allergy
boolean
C0009488 (UMLS CUI [1])